1.

[Article] Chen, Shuoqi and Aldabergenov, Daniyar and Alotaibi, Khalid S and Holland, Adam and Moore, Robert and Woodhouse, Rebecca and Hudson, Simon and Milton, Holly and Menzies, Eleanor and Parks, Claire and Lawson, Alexander J and Harris, Magdalena and Singer, Mervyn and Dyson, Alex and Copeland, Caroline S (2026) Is nitazene-related mortality underestimated? Findings from an in vivo and ex vivo rat study and pharmacoepidemiological analysis of coroner-reported deaths. Clinical Toxicology, Early online. https://doi.org/10.1080/15563650.2025.2601141

2.

[Article] Metrik, Jane and Bush, Nicholas and Gunn, Rachel L and McCarthy, Denis M (2026) Recent advances in the science of cannabis-impaired driving. Current Addiction Reports, 13. https://doi.org/10.1007/s40429-025-00712-0

3.

[Article] Nasir, Nirul Isamuddin and Ja'afar, Mohd Hasni and Ahmad, Norfazilah (2026) Systematic review of lung function assessment among youth and young adults e-cigarette users: Current tools and emerging methods. PLoS ONE, 21, (2). https://doi.org/10.1371/journal.pone.0342500

4.

[Article] McCrory, S and Sharif, F and Burke, J and Harper, A (2026) Fetal Alcohol Spectrum Disorder in Ireland. Irish Medical Journal, 119, (1), p. 17.

5.

[Article] Berrío, Ángela I and Sampietro, Hernán María and Barrios, Maite and Hidalgo Montesinos, María Dolores and Martín-Ordiales, Nuria and Guilera, Georgina (2026) The Dispositional Hope Scale in Spanish-speaking users of mental health services: validation and normative data. BMC Psychology, Early online. https://doi.org/10.1186/s40359-025-03859-7

6.

[Article] Bastien, Gabriel and Abboud, Anita and McAnulty, Christina and Mahroug, Amani and Le Foll, Bernard and Socias, M Eugenia and Juteau, Louis-Christophe and Dubreucq, Simon and Jutras-Aswad, Didier (2026) Concordance between urine drug screening and self-reported use in the context of a pragmatic randomized-controlled trial in people with prescription-type opioid use disorder: Concordance entre le dépistage de drogues dans l'urine et l'usage autodéclaré dans le contexte d'un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d'opioïdes vendus sur ordonnance. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 71, (1), pp. 41-52. https://doi.org/10.1177/07067437251367180

7.

[Report] Clean Slate Clinic, Adfam, The University of Sussex. (2026) Impact and barriers: a national survey of UK adults on alcohol dependence. Essex: Clean Slate Clinic, Adfam, The University of Sussex.

8.

[Report] Public Health Scotland. (2026) Drug and Alcohol Information System overview of initial assessments for specialist drug and alcohol treatment 2024/25. Edinburgh: Public Health Scotland.

9.

[Report] Public Health Scotland. (2026) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2026. Edinburgh: Public Health Scotland.

10.

[Article] Burton, Robyn and Theron, Marieke and Semple, Sean and Shield, Kevin and Parry, Charles D H (2026) Mind the gap: rethinking global alcohol metrics in high-abstention low-income and middle-income countries. The Lancet Global Health, 14, (1). DOI: 10.1016/S2214-109X(25)00396-1

11.

[Article] Sommer, Michaela J and Grafinger, Katharina Elisabeth and Hermanns-Clausen, Maren and Auwärter, Volker (2025) Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well-documented intoxication cases and basic pharmacological data. Addiction, Early online. https://doi.org/10.1111/add.70268

12.

[Article] Frinculescu, Anca and Köring, Alexander and Shine, Trevor and Ramsey, John and Frascione, Nunzianda and Abbate, Vincenzo (2025) Diazepam quantification in street tablets using benchtop 1H qNMR spectroscopy: method validation and its application. Quantitative NMR Journal, 1. https://doi.org/10.64225/953ws951

13.

[Article] Goal, Oliver Ethan and Amanda, Isca and Adams, Cameron and Grando, Maria Adela (2025) A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures. Annals of Medicine, 57, (1). https://doi.org/10.1080/07853890.2024.2447413

14.

[Audio] Society for the Study of Addiction. (2025) Addiction audio. Season 3, 2025. London: Society for the Study of Addiction.

15.

[Report] UK Department of Health and Social Care. (2025) Clinical guidelines for alcohol treatment. London: Department of Health and Social Care.

16.

[Article] Musetti, Alessandro and Floros, Georgios and Chiappedi, Matteo and Stavropoulos, Vasileios (2025) Gaming disorder in the ICD-11: the state of the game. BMC Psychiatry, 25. https://doi.org/10.1186/s12888-025-07576-8

17.

[Article] Tryggedsson, Jeppe Sig Juelsgaard and Andersen, Kjeld and Nielsen, Anette Søgaard and Olsen, Camilla Dahl Haislund and Mellentin, Angelina Isabella (2025) Quality of life assessment instruments used in clinical trials for alcohol use disorder: a systematic review. Journal of Substance Use and Addiction Treatment, 178. DOI: 10.1016/j.josat.2025.209793

18.

[Report] Public Health Scotland. (2025) Rapid Action Drug Alerts and Response (RADAR) quarterly reports 2025. Edinburgh: Public Health Scotland.

19.

[Article] Oz, Esin and Kasikci, Merve and Celik, İbrahim and Gurler, Mukaddes (2025) Metabolic profile of male cannabis users and estimation of candidate biomarkers. Chemical Research in Toxicology, 38, (10), pp. 1762-1770. https://pubs.acs.org/doi/10.1021/acs.chemrestox.5c00274

20.

[Article] Vojt, Gabriele and Bonnet, Philippe and Scott, Jennifer and Hathorn, Emma and Ellis, Lisa and Bufton, Sally and Mutimer, David and Buchanan, Ryan and Reid, Leila and Morris, Danny and Elsharkawy, Ahmed (2025) Peer-delivered outreach with rapid treatment pathways for hepatitis C testing and treatment among unhoused people. Journal of Viral Hepatitis, 32, (10). https://doi.org/10.1111/jvh.70085

21.

[Report] Riches, E and McMillan, G and Patterson, C (2025) Interventions to reduce harms from cocaine. A scoping review. Edinburgh: Public Health Scotland.

22.

[Article] Lopez, Audrey and Cohen, Audrey Sarah and Vega, Francine and Champagne-Langabeer, Tiffany (2025) Implementation of screening and assessment tools for diagnosing opioid use disorder: a systematic review. Drug and Alcohol Dependence Reports, 16. https://doi.org/10.1016/j.dadr.2025.100375

23.

[Article] Eikelboom, Willem S and Verberkt, Denice S A M and Rensen, Yvonne C M and Janssen, Gwenny T L and Kessels, Roy P C (2025) Assessment of agitation and aggression in inpatients with alcohol use disorder: a systematic review of informant-based scales. Alcohol, Clinical & Experimental Research, 49, (9), pp. 1877-1888. https://doi.org/10.1111/acer.70138

24.

[Article] Marland, Victoria and Nisbet, Lorna and Nic Daéid, Niamh (2025) Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples. Harm Reduction Journal, 22. https://doi.org/10.1186/s12954-025-01287-9

25.

[Article] Trotta, Giulia and Spinazzola, Edoardo and Degen, Hannah and Li, Zhikun and Austin-Zimmerman, Isabelle and Leung, Bok Man and Lang, Yifei and Rodriguez, Victoria and Aas, Monica and Sideli, Lucia and Wolff, Kim and Freeman, Tom P and Murray, Robin M and Wong, Chloe C Y and Alameda, Luis and Di Forti, Marta (2025) The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach. Psychological Medicine, 55. 10.1017/S0033291725101190

26.

[Article] Farinelli, Lisa A and Sherman, Garrick and Piacentino, Daria and Schwandt, Melanie L and Abreu, Valerie Espinal and Cooper, Diane and Leggio, Lorenzo (2025) Early signs of cardiovascular abnormalities in patients with alcohol misuse. Alcohol, clinical & experimental research, 49, (8), pp. 1704-1715. https://doi.org/10.1111/acer.70099

27.

[Report] Pan American Health Organization. (2025) Strategic plan for an integrated public health laboratory system in the Americas 2025–2030. Washington DC: Pan American Health Organization.

28.

[Article] Lindert, Jutta and Behr, Kim-Julian and Arndt, Sarah and Jakubauskiene, Marija and Bain, Paul A and Milin, Sascha and Schuh, Lisa Marie and Schäfer, Ingo (2025) Measuring substance use in refugees: a systematic review of assessment instruments. Substance Use & Addiction Journal, 46, (4), pp. 1070-1088. https://doi.org/10.1177/29767342251348146

29.

[Webpage] Center for Forensic Science Research and Education. (2025) CSFRE new psychoactive substances (NPS). Scope recommendations. URL: https://www.cfsre.org/nps-discovery/scope-recommen...

30.

[Report] Morris, D and Gillespie, D and Chen, RKL and Wilson, L and Brennan, A and Holmes, J and Angus, Colin (2025) New modelling of alcohol pricing policies, alcohol consumption and harm in Wales: an adaptation of the Sheffield Tobacco and Alcohol Policy Model v2.6.0. Cardiff: Welsh Government.

31.

[Article] Carlin, Victoria E and LaRowe, Lisa R and Ditre, Joseph W (2025) Pain intensity and hazardous cannabis use: the moderating role of pain-related anxiety. Journal of Psychoactive Drugs, Early online. pp. 1-8. https://doi.org/10.1080/02791072.2025.2511756

32.

[Video] Piatkowski, Timothy (2025) NDARC webinar series presentation: Findings from Wave 2 of the world-first steroid checking trial. National Drug and Alcohol Research Centre, UNSW Sydney.

33.

[Article] Kenny, Pheena and Swinburne, Lynn and Houghton, Sean and White, Philippa and Watchorn, Joanne and O'Donovan, Niamh and Buckley, Elaine and Tobin, Laura and Kabir, Zubair and Russell, Noirin and Blake, Martina (2025) Smoking, human papilloma virus and cervical cancer: a colposcopy clinic partnership project. Tobacco Induced Diseases, 23, (Supp 1).

34.

[Article] Marongiu, Sabrina and van Eijk, Maarten and Gresnigt, Femke M J and Croes, Esther A and Franssen, Eric J F (2025) Rising incidence of recreational ketamine use: clinical cases and management in emergency settings. Toxicology reports, 14. https://doi.org/10.1016/j.toxrep.2025.101940

35.

[Article] Ragan-Burnett, Kathleen and Schieber, Lyna and Terranella, Andrew and Mikosz, Christina (2025) Substance use screening, brief intervention, and referral to treatment among youth-serving clinicians. JAMA Network Open, 8, (5). 10.1001/jamanetworkopen.2025.11579

36.

[Article] NIAAA. (2025) Alcohol use disorder: from risk to diagnosis to recovery. The Healthcare Professional's Core Resource on Alcohol,

37.

[Article] Pontes, Halley M and Selak, Špela and Žmavc, Mark and Griffiths, Mark D (2025) Initial development and psychometric properties of the Gambling Disorder Test in a nationally representative sample of adults. Psychological assessment, 37, (5), pp. 237-248. https://doi.org/10.1037/pas0001374

38.

[Article] Ware, Owen D and Geiger, Gabriella Rose and Rivas, Veronica D and Macias Burgos, Miracle A and Nehme-Kotocavage, Lea and Bautista, Tara G (2025) Risk of relapse following discharge from non-hospital residential opioid use disorder treatment: a systematic review of studies published from 2018 to 2022. Substance Abuse and Rehabilitation, 16. pp. 105-118. https://doi.org/10.2147/SAR.S440214

39.

[Report] European Drugs Agency. (2025) Wastewater analysis and drugs — a European multi-city study. Lisbon: European Drugs Agency.

40.

[Article] Bade, Richard and Nadarajan, Dhayaalini and Hall, Wayne and Brown, Jared A and Schumann, Jennifer (2025) Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: two years of data from 22 countries. Addiction, 120, (9), pp. 1739-1746. https://doi.org/10.1111/add.70027